AOL Money & Finance

Amdocs posts

Feed

Global Q&A: Still a believer in growth

I am the Global Editor at MoneyShow.com and each week I interview an investing expert. This week, I spoke with Vahan Janjigian, editor of Forbes Growth Investor, who discusses how the economic crisis affects his strategy and mentions some good international growth stocks.

Q. Vahan, although you primarily recommend US equities, your newsletter also includes a few international picks, such as American Oriental Bioengineering (NYSE: AOB) and Embraer (NYSE: ERJ). What factors made you choose these companies?

A. I do recommend foreign companies from time to time in the Forbes Growth Investor, but only if they trade on US exchanges and only if they show up at the top of my screens. I rely on a quantitative model that screens stocks based on the probability of out-performance over the next six to 18 months. I like AOB because it sells traditional Chinese plant-based pharmaceuticals in China. Demand is very strong for these natural products in that country. I like ERJ because it gives us exposure to Brazil, which has one the fastest growing economies in Latin America.

Q. Several of your recommendations are US-based multinationals, such as RPM (NYSE: RPM) and Amdocs (NYSE: DOX), both of whom do significant business around the world. How important was their international exposure to your selection, and why?

A: International exposure is not something I normally focus on. Besides, these days most mid- to large-sized companies have at least some international exposure. Because the global economic outlook is so uncertain at this time, I felt more comfortable with companies that have a diversified revenue stream.

Continue reading Global Q&A: Still a believer in growth

Earnings highlights: Bank of America, Merck, Mattel, Phillip Morris, AFLAC and others

Here are some highlights from this past week's earnings coverage from BloggingStocks:

Continue reading Earnings highlights: Bank of America, Merck, Mattel, Phillip Morris, AFLAC and others

Amdocs has record quarter

Amdocs Limited (NYSE: DOX), the software company that specializes in telecom billing solutions, announced record quarterly revenues. On the news the stock closed up $6.27. The Israeli company beat estimates and re-affirmed full year guidance.

"We are pleased with our results for the first quarter of fiscal 2008 and believe that we are positioned to achieve our goals for this fiscal year," said Dov Baharav, chief executive officer of Amdocs Management Limited. "This was a very good quarter in terms of new sales, highlighted by the significant expansion of our managed services activities at AT&T and our win at Sprint."

With a strong quarter and continued new deals like those with AT&T Inc. (NYSE: T) and Sprint Nextel Corporation (NYSE: S), along with their push into mobile billing solutions, the stock continues to be one of our favorites for '08.

Aaron Katsman is the lead Portfolio Manager and Managing Director of America Israel Investment Associates, LLC. and Senior Editor of IsraelNewsletter.com. DISCLOSURE: Writer has a position and is long DOX. He has no positions in any stock mentioned as of 1/23/08

A great 48 hours for Amdocs (DOX)

I had no idea when I posted yesterday about two Israeli stocks to buy for a market bounce that one of the stocks I mentioned would spike more than 10%. Amdocs Limited (NYSE: DOX) is the market leader in customer experience systems innovation, enabling world-leading service providers to deliver an integrated, innovative and intentional customer experience at every point of service.

The company has experienced one heck of a 48 hours. On Tuesday there was the news that Sprint/Nextel Corporation (NYSE: S) is soft-launching a WiMAX network, and picked communications software company Amdocs to build and maintain the Xohm web portal and manage its customer service, billing, and other operations.

Even bigger is the news today that Amdocs signed a deal to provide support services to AT&T (NYSE: T), which one analyst estimated is worth more than $100 million a year. Wedbush Morgan analyst Scott P. Sutherland reiterated a "Strong Buy" rating on Amdocs, and estimated that the deal "is initially worth well over $100 million annually and has the potential to be even more."

Continue reading A great 48 hours for Amdocs (DOX)

2 Israeli stocks to buy for the bounce

With markets continuing their downward spiral, many investors think that it's time to step up and start buying some stocks that have been beaten down. Here are two hot Israeli stocks that have been cool for investors during the recent market sell-off.

Amdocs Limited (NYSE: DOX) is the market leader in customer experience systems innovation, enabling world-leading service providers to deliver an integrated, innovative and intentional customer experience at every point of service. The stock has gotten hit of late, but with a PE of about 18 and a PEG slightly under 1, the stock is looking attractive.

With the news that Sprint/Nextel Corporation (NYSE: S) is soft-launching a WiMax network, and picked communications software company Amdocs to build and maintain the Xohm Web portal and manage its customer service, billing, and other operations. The company is also gearing up to be the big winner in mobile phone billing as well, and that vertical could add significant revenue to the company.

Alon USA Energy, Inc. (NYSE: ALJ) engages in refining and marketing petroleum products primarily in the south central, southwestern, and western regions of the United States. The stock has gotten crushed as crude prices soared, losing more than 50% from its high. The company sports a low PE of just 6.25 and a PEG of 0.8. If crude prices stabilize, Alon will be a big winner.

Aaron Katsman is the lead Portfolio Manager and Managing Director of America Israel Investment Associates, LLC. and Senior Editor of IsraelNewsletter.com. DISCLOSURE: Writer's fund has a position and owns stock in both DOX and ALJ and is long them both.He has no positions in any other stock mentioned as of 1/9/08.


Analyst downgrades: STM, BIIB, ACBA and XTXI

MOST NOTEWORTHY: STMicroelectronics, Biogen Idec, American Community Bank and Crosstex Energy were today's notable downgrades:
  • Lehman downgraded STMicroelectronics (NYSE: STM) to Underweight from Overweight, as they expect the company to underperform its peers.
  • UBS downgraded Biogen Idec Inc (NASDAQ: BIIB) to Sell from Neutral, citing valuation and their belief that there would be no significant premium if the company was bought.
  • American Community Bancshares (NASDAQ: ACBA) was downgraded to Hold from Buy at Stifel, based on valuation.
  • Goldman Sachs downgraded Crosstex Energy Inc (NASDAQ: XTXI) to Neutral from Buy, citing valuation.
OTHER DOWNGRADES:
  • PepsiAmericas Inc (NYSE: PAS) was downgraded to Underweight from Neutral by HSBC.
  • Amodcs Ltd (NYSE: DOX) was removed from the Conviction Buy List by Goldman Sachs.
  • Citigroup assumed coverage of Tenneco Inc (NYSE: TEN) with a Sell from a Hold.
  • Morgan Stanley downgraded LDK Solar (NYSE: LDK) to Equal Weight from Overweight.

Analyst initiations 7-20-07: AEO, DOX, MFE and PSUN

MOST NOTEWORTHY: McAfee (MFE), Wabtec Corp (WAB), Pacific Sunwear (PSUN), Aeropostale (ARO) and Amdocs (DOX) were today's noteworthy initiations:
  • McAfee Inc (NYSE: MFE) was initiated with an Accumulate rating at ThinkEquity, as the firm is positive on the company's competitive positioning in security, refocused business and streamlined operations.
  • JP Morgan initiated shares of Wabtec Corp (NYSE: WAB) with an Overweight rating, as the firm believes Wabtec's strong market presence should support 22% and 12% EPS growth in 2007 and 2008.
  • Nollenberger feels that the core PacSun concept is challenged to re-establish a niche in the competitive teen marketplace, and initiated shares of Pacific Sunwear (NASDAQ: PSUN) with a Neutral rating and $22 target.
  • Nollenberger also initiated shares of Aeropostale (NYSE: AEO) with a Buy rating and $49 target and recommends buying the stock into back to school.
  • Cantor initiated shares of Amdocs (NYSE: DOX) with a Hold rating and $37 target on valuation...
OTHER INITIATIONS:
  • JP Morgan also initiated shares of Greenbrier (NYSE: GBX) with a Neutral rating.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).

This week's rumor round-up: Lam Research close to sale?

Heading to Memorial Day, there's certainly no moratorium on the number of talked about potential deals. Receiving a fair amount of attention over the last few days include the companies below. There's more, of course, but hey, it's a three-day weekend.

LAM RESEARCH CORPORATION (NASDAQ: LRCX)

This supplier of tools that makes microchips keeps seeing its stock move up. Up about 13% over the last few months. And it may be more than speculation that it will soon be acquired. Investors looking for a deal are snapping up equity calls, some are then selling them, and keeping both eyes on the stock price. Others are looking out to see which private equity firms or "strategic" buyers come calling.

AMDOCS LIMITED (NYSE: DOX)

As Alltel Corporation (NYSE: AT) goes, so goes Amdocs? Well, not quite. Yes the Alltel sale has pushed Amdocs' stock upward. Some say this maker of software products for telecom services firms may want to continue to go forward by themselves. But that hasn't stopped that list of potential buyers from being passed around. Best bet: International Business Machines Corporation (NYSE: IBM).

CIRCUIT CITY STORES (NYSE: CC)

Again, here we go: Is it going to take a buyout? (Read: private equity buyer.) Or a miracle? (Read: new management) There are profit warnings. (Read: red flags everywhere) The stock is in miserable shape. (Read: cheap) Tough competition. (Read: Wal-Mart Stores Inc (NYSE: WMT)). Think there's a book to be written about all of this? (Read: who'd want to?).

APPLEBEE'S INTERNATIONAL INC (NASDAQ: APPB)

Food for thought. Kangaroo Holdings wants to buy OSI Restaurant Partners Inc (NYSE: OSI). Not surprisingly, Applebee's stock goes up. Are they cooking up a sale price for themselves as they "evaluate" offers? You betcha.

PALM INC (NASDAQ: PALM)

Going, going...almost gone. Even we're beginning to tire of this one. But it never gets old if you like to watch. Now, they're canceling conferences. The CEO is selling shares. The CFO has a bad back. Come on! The latest product review - Palm Treo 755p - is terrible. Market share is going down the tubes. R&D? Forgetaboutit. Sound like a company on the go? Right. Right into someone else's lap. And to think what they once were. Great job all around, everybody.

Symbol Lookup
IndexesChangePrice
DJIA+73.0010,270.47
NASDAQ+18.862,167.88
S&P 500+6.241,093.48

Last updated: November 14, 2009: 12:48 PM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

WalletPop Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance